RABGAP1L
Rab GTPase-activating protein 1-like
Also known as: FLJ38519, HHL, KIAA0471, RBG1L_HUMAN, TBC1D18
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5R372
- Gene
- RABGAP1L
- Ensembl
- ENSG00000152061
- Chromosome
- 1
- Canonical length
- 815 aa
- Protein class
- Disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables GTPase activator activity and small GTPase binding activity. Acts upstream of or within regulation of protein localization. Located in several cellular components, including Golgi apparatus; cilium; and early endosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
815 residues, UniProt reviewed canonical sequence.
>Q5R372|RABGAP1L
1 MEVRASLQKV SGSSDSVATM NSEEFVLVPQ YADDNSTKHE EKPQLKIVSN GDEQLEKAME
61 EILRDSEKRP SSLLVDCQSS SEISDHSFGD IPASQTNKPS LQLILDPSNT EISTPRPSSP
121 GGLPEEDSVL FNKLTYLGCM KVSSPRNEVE ALRAMATMKS SSQYPFPVTL YVPNVPEGSV
181 RIIDQSSNVE IASFPIYKVL FCARGHDGTT ESNCFAFTES SHGSEEFQIH VFSCEIKEAV
241 SRILYSFCTA FKRSSRQVSD VKDSVIPTPD SDVFTFSVSL EVKEDDGKGN FSPVPKDRDK
301 FYFKLKQGIE KKVVITVQQL SNKELAIERC FGMLLSPGRN VKNSDMHLLD MESMGKSYDG
361 RAYVITGMWN PNAPVFLALN EETPKDKQVY MTVAVDMVVT EVVEPVRFLL ETVVRVYPAN
421 ERFWYFSRKT FTETFFMRLK QSEGKGHTNA GDAIYEVVSL QRESDKEEPV TPTSGGGPMS
481 PQDDEAEEES DNELSSGTGD VSKDCPEKIL YSWGELLGKW HSNLGARPKG LSTLVKSGVP
541 EALRAEVWQL LAGCHDNQAM LDRYRILITK DSAQESVITR DIHRTFPAHD YFKDTGGDGQ
601 ESLYKICKAY SVYDEDIGYC QGQSFLAAVL LLHMPEEQAF CVLVKIMYDY GLRDLYRNNF
661 EDLHCKFYQL ERLMQEQLPD LHSHFSDLNL EAHMYASQWF LTLFTAKFPL CMVFHIIDLL
721 LCEGLNIIFH VALALLKTSK EDLLQADFEG ALKFFRVQLP KRYRAEENAR RLMEQACNIK
781 VPTKKLKKYE KEYQTMRESQ LQQEDPMDRY KFVYLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RABGAP1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 115 nTPM
- tonsil: 44 nTPM
- lymph node: 36 nTPM
- testis: 29 nTPM
- bone marrow: 28 nTPM
- spleen: 24 nTPM
Single-cell type
- pdcs: 2,128 nCPM
- choroid plexus epithelial cells: 1,941 nCPM
- cardiomyocytes: 1,614 nCPM
- podocytes: 1,592 nCPM
- nk-cells: 1,173 nCPM
- retinal pigment epithelial cells: 1,138 nCPM
Immune cell
- non-classical monocyte: 179 nTPM
- eosinophil: 108 nTPM
- neutrophil: 87 nTPM
- intermediate monocyte: 85 nTPM
- NK-cell: 80 nTPM
- plasmacytoid DC: 53 nTPM
Brain region
- choroid plexus: 149 nTPM
- cerebellum: 143 nTPM
- cerebral cortex: 95 nTPM
- white matter: 93 nTPM
- hypothalamus: 90 nTPM
- basal ganglia: 89 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RABGAP1L.
Disease | AllUniProt
Conditions RABGAP1L is implicated in, by any mechanism.
- Leukemia, acute myelogenous (AML) MIM:601626
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RABGAP1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RABGAP1L as an antibody target. Whether an autoantibody or antibody against RABGAP1L could matter depends on whether native RABGAP1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RABGAP1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RABGAP1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...